Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30)
Multhoff, Gabriele, Combs, Stephanie E., Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim
, Blankenstein, Christiane, Hildebrandt, Martin, Kokowski, Konrad, Hautmann, Matthias, Hautmann, Hubert, Rödel, Claus, Fietkau, Rainer, Huber, Rudolf
, Haller, Bernhard, Ertl, Christine, Devecka, Michal, Offner, Robert
and Ahrens, Norbert
(2020)
Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30).
Cancer research 80 (16supp).
Date of publication of this fulltext: 03 Nov 2021 06:36
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancer research | ||||
| Publisher: | American Association for Cancer Research | ||||
|---|---|---|---|---|---|
| Place of Publication: | PHILADELPHIA | ||||
| Volume: | 80 | ||||
| Number of Issue or Book Chapter: | 16supp | ||||
| Date | August 2020 | ||||
| Institutions | Medicine > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin Medicine > Lehrstuhl für Strahlentherapie | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Partially | ||||
| Item ID | 50865 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric